will compounded glp 1 go away FDA is moving to restrict mass-marketed GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Compounded GLP-1 drugs aren't going
Description
Tirzepatide is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those diagnosed with multiple endocrine neoplasia syndrome type 2, due to a theoretical risk of thyroid tumors based on animal studies
Will there be unwanted interactions or would these drugs together prove to be safe and effective
&srotate=0)
Over up to 10 years of follow-up, GLP-1 therapy was associated with lower rates of cirrhosis complications compared with surgery
Whatever the reason, switching requires careful planning
